DARA BioSciences, Inc.·4

May 16, 5:11 PM ET

FRANCO RICHARD A 4

4 · DARA BioSciences, Inc. · Filed May 16, 2011

Insider Transaction Report

Form 4
Period: 2011-05-12
FRANCO RICHARD A
DirectorPresident & CEO
Transactions
  • Conversion

    Common Stock

    2011-05-122000 total
    Exercise: $2.50Common Stock (80,000 underlying)
  • Conversion

    Common Stock

    2011-05-12$2.50/sh+80,000$200,000246,334 total
Footnotes (1)
  • [F1]The reporting person converted 200 shares of Series A Convertible Preferred Stock into 80,000 shares of common stock. The Series A Convertible Stock had a stated value of $1,000 per share and was convertible into common stock at a conversion price of $2.50.

Documents

1 file
  • 4
    rrd311496.xmlPrimary

    FORM 4